Haematological Cancers

The incidence rates for haematological cancers in the UK are higher than in Europe for each type of haematological cancer.

For leukaemia, the UK incidence rate is 9.7 per 100,000 of the population compared to 9.2 per 100,000 on average in Europe. In comparison to the other EURO4 countries, the UK has the second highest incidence rate for leukaemia.

For Hodgkin’s lymphoma, the incidence rate in the UK is 2.5 per 100,000. Whilst this is higher than the European average of 2.3 per 100,000, it is equal to the average of the four other major European countries.

For Non-Hodgkin lymphoma, the UK incidence rate is 14.2 per 100,000 of the population compared to 11.6 per 100,000 on average in Europe. In comparison to the other EURO4 countries, the UK has the second highest incidence rate for Non-Hodgkin lymphoma.

EUCAN, Cancer factsheets, 2012. Available at http://eco.iarc.fr/EUCAN

EUCAN, Cancer factsheets, 2012. Available at http://eco.iarc.fr/EUCAN

EUCAN, Cancer factsheets, 2012. Available at http://eco.iarc.fr/EUCAN

The mortality rate for haematological cancers in the UK is lower than the EU average.

In terms of the mortality rate for leukaemia, the UK has a lower mortality rate than the EU average. The mortality rate in the UK is 4.8 per 100,000 compared to the European average of 5.2 per 100,000. Furthermore, the mortality rate in the UK is lower than all other EURO4 countries apart from Spain.

The mortality rate for Hodgkin lymphoma in the UK is the same as the European average - 0.4 per 100,000 but it is the second highest among the other EURO4 countries.

World Health Organisation, Cancer Mortality database, 2012. Available at http://www-dep.iarc.fr/WHOdb/WHOdb.htm

World Health Organisation, Cancer Mortality database, 2012. Available at http://www-dep.iarc.fr/WHOdb/WHOdb.htm

World Health Organisation, Cancer Mortality database, 2012. Available at http://www-dep.iarc.fr/WHOdb/WHOdb.htm

World Health Organisation, Cancer Mortality database, 2012. Available at http://www-dep.iarc.fr/WHOdb/WHOdb.htm

For Leukaemia, the UK five-year survival rate is 1.5% higher than the European average. Despite this, the UK five-year survival rate in comparison to the other EURO4 countries is still behind that of France and Germany.

The UK five-year survival rate for Hodgkin lymphoma is 3.7% lower than the European average. The UK five-year survival rate for this cancer is the lowest among the EURO4 countries.

For Non-Hodgkin lymphoma, the UK five-year survival rate is 2% lower than the European average of 59.8% and it is the lowest five-year survival rate for this cancer among the EURO4 countries.

EUROCARE, database 5, 2014. Available at http://www.eurocare.it/Database/tabid/77/Default.aspx
EUROCARE, Data and methods, 2014. Available at https://w3.iss.it/site/EU5Results/docs/Documentation_on_data_and_methods.pdf

EUROCARE, database 5, 2014. Available at http://www.eurocare.it/Database/tabid/77/Default.aspx
EUROCARE, Data and methods, 2014. Available at https://w3.iss.it/site/EU5Results/docs/Documentation_on_data_and_methods.pdf

EUROCARE, database 5, 2014. Available at http://www.eurocare.it/Database/tabid/77/Default.aspx
EUROCARE, Data and methods, 2014. Available at https://w3.iss.it/site/EU5Results/docs/Documentation_on_data_and_methods.pdf

Patient Experience

When compared to other cancers, patient experience for haematological cancer patients in the UK presents a mixed picture.

According to the 2015 National Cancer Patient Experience Survey, which surveys over 100,000 cancer patients in the UK, haematological cancer patients rated their speed of diagnosis as slightly better than people with other types of cancer and their understanding of the treatment options available to them as being slightly worse.

However, four out of ten patients did not understand their condition.1 This compares very poorly with patients with other types of cancer, nearly three quarters of whom did understand their condition adequately.